Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Heweizhixie (also known as Heweizhixie Capsule) is a Traditional Chinese Medicine (TCM) product developed by the Shanghai University of Traditional Chinese Medicine for the treatment of diarrhea. The formulation is designed to harmonize the stomach and spleen, addressing gastrointestinal distress and loose stools associated with spleen-stomach disharmony. As a TCM product, it consists of a complex mixture of botanical extracts that work synergistically to regulate intestinal motility and fluid balance. The drug has undergone Phase IV clinical evaluation in China to further assess its safety and therapeutic efficacy in a real-world post-marketing setting, indicating it is an approved pharmaceutical product in its home market.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Heweizhixie.